Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE 2:38:10 PM EDT
| Market Cap (Intraday) | 4.98B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $55.51 |
| 50-Day MA | $54.06 |
| 200-Day MA | $47.13 |
Ultragenyx Pharmaceutical Inc. Stock, NASDAQ:RARE
60 Leveroni Court, Novato, California 94949
United States of America
Phone: +1.415.483.8800
Number of Employees: 1276
Description
Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010, and is headquartered in Novato, CA.